0001246360-14-003324.txt : 20140729 0001246360-14-003324.hdr.sgml : 20140729 20140729200716 ACCESSION NUMBER: 0001246360-14-003324 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140728 FILED AS OF DATE: 20140729 DATE AS OF CHANGE: 20140729 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDTRONIC INC CENTRAL INDEX KEY: 0000064670 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 410793183 STATE OF INCORPORATION: MN FISCAL YEAR END: 0425 BUSINESS ADDRESS: STREET 1: 710 MEDTRONIC PKWY STREET 2: MS LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 BUSINESS PHONE: 7635144000 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PKWY CITY: MINNEAPOLIS STATE: MN ZIP: 55432 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COYLE MICHAEL J CENTRAL INDEX KEY: 0001233311 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07707 FILM NUMBER: 141001010 MAIL ADDRESS: STREET 1: ONE LILLEHEI PLAZA CITY: ST. PAUL STATE: MN ZIP: 53717 4 1 form.xml PRIMARY DOCUMENT X0306 4 2014-07-28 false 0000064670 MEDTRONIC INC MDT 0001233311 COYLE MICHAEL J 710 MEDTRONIC PKWY MS LC300 MINNEAPOLIS MN 55432 false true false false EVP & Group Pres, Cardiac&Vasc Common Stock 3738.526 I by spouse Common Stock 250 I by family trust Common Stock 2014-07-28 4 A false 14213 0 A 93592.04 D Employee Stock Option (right to buy) 62.76 2014-07-28 4 A false 56852 0 A 2015-07-28 2024-07-28 Common Stock 56852 56852 D Employee Stock Option (right to buy) 62.76 2014-07-28 4 A false 1594 0 A 2015-07-28 2024-07-28 Common Stock 1594 58446 D These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. This balance increased by 268.746 shares due to exempt transactions such as dividend reinvestment. The restrictions on such units shall lapse 100% on the third anniversary of the Grant Date if the Companys cumulative diluted earnings per share growth during the 36 month period ending on the last day of the Companys fiscal year 2017 equals or exceeds a 3% compound annual growth rate, as determined by the Compensation Committee. Rhonda L. Ingalsbe, Attorney-in-fact 2014-07-29